Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema

Roderick O’Day1 Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, NSW, AustraliaCorrespondence[email protected]

Daniel Barthelmes1 Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, NSW, Australia

Meidong Zhu1 Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, NSW, Australia

Tien Yin Wong2 Singapore Eye Research Institute, National University of Singapore, Singapore;3 Center for Eye Research Australia, The University of Melbourne, Melbourne, VIC, Australia

Ian L McAllister4 Lions Eye Institute, The University of Western Australia, Perth, WA, Australia

Jennifer J Arnold5 Marsden Eye Specialists, Sydney, NSW, Australia

Mark C Gillies1 Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, NSW, Australia

show all

Pages 1565-1570 | Published online: 02 Aug 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

CheungNMitchellPWongTYDiabetic retinopathyLancet2010376973512413620580421
PubMed Web of Science ®Google Scholar
KempenJHO’ColmainBJLeskeMCThe prevalence of diabetic retinopathy among adults in the United StatesArch Ophthalmol2004122455256315078674
PubMed Web of Science ®Google Scholar
KleinRKleinBEMossSEDavisMDDeMetsDLThe Wisconsin epidemiologic study of diabetic retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 yearsArch Ophthalmol198410245205266367724
PubMedGoogle Scholar
SjolieAKStephensonJAldingtonSRetinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications StudyOphthalmology199710422522609052629
PubMed Web of Science ®Google Scholar
KohnerEMDiabetic retinopathyClin Endocrinol Metab197762345375330038
PubMedGoogle Scholar
ZimmetPAlbertiKGShawJGlobal and societal implications of the diabetes epidemicNature2001414686578278711742409
PubMed Web of Science ®Google Scholar
MohamedQGilliesMCWongT YManagement of diabetic retinopathy: a systematic reviewJAMA2007298890291617712074
PubMed Web of Science ®Google Scholar
SutterFKSimpsonJMGilliesMCIntravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trialOphthalmology2004111112044204915522370
PubMed Web of Science ®Google Scholar
GilliesMCSutterFKSimpsonJMLarssonJAliHZhuMIntravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trialOphthalmology200611391533153816828501
PubMed Web of Science ®Google Scholar
GilliesMCSimpsonJMGastonCFive-year results of a randomized clinical trial with open-label extension of intravitreal triamcinolone for refractory diabetic macular edemaOphthalmology2009116112182218719796823
PubMed Web of Science ®Google Scholar
GilliesMCMcAllisterILZhuMIntravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trialOphthalmology2011118586687221232801
PubMedGoogle Scholar
ElmanMJAielloL PBeckRWDiabetic Retinopathy Clinical Research NetworkRandomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaOphthalmology201011761064107720427088
PubMed Web of Science ®Google Scholar
GilliesMCIslamFMZhuMLarssonJWongT YEfficacy and safety of multiple intravitreal triamcinoloone injections for refractory diabetic macular oedemaBr J Ophthalmol200791101323132617405800
PubMedGoogle Scholar
JonasJBDegenringRFKreissigIAkkoyunIKamppeterBAIntraocular pressure elevation after intravitreal triamcinolone acetonide injectionOphthalmology2005112459359815808249
PubMed Web of Science ®Google Scholar
GilliesMCKuzniarzMCraigJBallMLuoWSimpsonJMIntravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataractOphthalmology2005112113914315629834
PubMed Web of Science ®Google Scholar
GilliesMCMcAllisterILZhuMPretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trialInvest Ophthalmol Vis Sci20105152322232820019369
PubMed Web of Science ®Google Scholar
Sanchez-TocinoHAlvarez-VidalAMaldonadoMJMoreno-MontanesJGarcia-LayanaARetinal thickness study with optical coherence tomography in patients with diabetesInvest Ophthalmol Vis Sci20024351588159411980878
PubMedGoogle Scholar
MohamedSLeungGMChanCKFactors associated with variability in response of diabetic macular oedema after intravitreal triamcinoloneClin Experiment Ophthalmol200937660260819702711
PubMedGoogle Scholar
GilliesMCSimpsonJMBillsonFASafety of an intravitreal injection of triamcinolone: results from a randomized clinical trialArch Ophthalmol2004122333634015006845
PubMedGoogle Scholar
KonstantopoulosAWilliamsC PNewsomRSLuffAJOcular morbidity associated with intravitreal triamcinolone acetonideEye (Lond)200721331732016710433
PubMed Web of Science ®Google Scholar
GilliesMCIslamFMLarssonJTriamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prosepective data from a randomized clinical trialClin Experiment Ophthalmol201038660561220528977
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date